Form 4: BeOne Medicines Officer Executes Mandatory Tax Sale

Principal Accounting Officer Titus B. Ball sold 136 American Depositary Shares to satisfy mandatory tax withholding obligations.

Summary

• Titus B. Ball, Principal Accounting Officer of BeOne Medicines Ltd., sold a total of 136 American Depositary Shares (ADS) on June 8, 2026.
• The transactions were executed in two batches: 100 ADS at a weighted average price of $271.0576 and 36 ADS at a weighted average price of $272.08.
• Following these transactions, the reporting person holds 0 American Depositary Shares, though retains 70,629 Ordinary Shares.
• Each ADS represents 13 Ordinary Shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely administrative to satisfy tax liabilities rather than a discretionary divestment.

Positives

• The sale was non-discretionary, triggered by mandatory tax withholding requirements related to the vesting of restricted share units.

Negatives

• The reporting person has reduced their direct holdings of American Depositary Shares to zero.

Risks

• Future tax obligations upon the vesting of remaining restricted share units may necessitate further sales of equity.

Future Outlook

The filing does not provide forward-looking guidance, as it is a mandatory disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that mandatory tax withholding sales are standard corporate governance procedures for executives receiving equity-based compensation and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for Section 16 officers.
• The use of mandatory sell-to-cover for tax obligations is a common practice among publicly traded biotechnology and pharmaceutical firms.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a pre-planned tax-related event.

Next Steps

• Continued vesting of remaining restricted share units on future anniversaries of June 5, 2024.

Key Dates

Keywords

BeOne Medicines, ONC, Insider Trading, Form 4, Tax Withholding, Equity Vesting